A solution of 180 mg of Chlorpromazine HCI in 5 ml of water, was lyophilized, and then was exposed for 7 days to 1,5 C of Tritium-gas, at a pressure of 240 mm Hg, at room temperature. The technique used has been described by Wenzel ( l ) . To remove labile bound tritium atoms, the labelled substance
Synthesis of deuterium-labelled chlorpromazine and chlorpromazine metabolites
โ Scribed by J. Cymerman Craig; L. D. Gruenke; S.-Y. Catherine Lee
- Publisher
- John Wiley and Sons
- Year
- 1978
- Tongue
- French
- Weight
- 325 KB
- Volume
- 15
- Category
- Article
- ISSN
- 0022-2135
No coin nor oath required. For personal study only.
โฆ Synopsis
The eyntheeie of 2-chloro-10-(3'-dimethylaminopropyl)phenothiazine-3', 3'-d2 (Chlorpromazine-d2) and ite four major metabolitee (the mono-and didemethylated aminee, chlorpromazine sulfoxide, and chlorpromazine N-oxide), all containing the 3',3'-d2 label in > 95% ieotopic purity, ie deecribed. Considerations leading to the optimum rider and poeition of the labels are diecuaeed, and the problem of coupling the aliphatic aide-chain to the tricyclic eyetem ie avoided by utilizing the readily available Z-chloro-10-(2'-cyanoethyl)phenothiazine as starting material, 80 that the carbon skeleton of the aide-chain ie already in poeition before the ieotope ie introduced.
๐ SIMILAR VOLUMES
Starting from 2,5,6-trideuter0-3,4-dihydroxyphenylethylamine, a mixture of 4,7-dideutero-5,6-dihydroxyindole, 4,7-dideutero-5-hydroxy--6-trideuteromethoxyindole and 4,7-dideutero-6-hydroxy-5-trideuteromethoxyindole was prepared. A similar procedure for the preparation of 4,7--dideutero-5,6-dihydroxy
Ultraviolet absorption and attenuated total reflectance infrared spectra of chlorpromazine and 14 possible metabolites have been recorded and analyzed. Structural correlations of the absorption bands are presented and discussed. This collection provides a positive means of identifying chlorpromazine
A procedure was standardized for extracting chloropromazine and its sulfoxide from the blood and for applying a recently developed fluorometric assay method to determine blood levels of these two compounds in schizophrenic patients receiving chlorpromazine therapy. The described methodology opens av